Medions Signium-14-S1-Reihe steht für kompakte, leichte Office-Notebooks im 14-Zoll-Format. Laut Medion bringen die Rechner ein Gewicht von knapp 1 kg auf die Waage. Aktuell führen Expert.de und ...
Do you doomscroll? If so, you’re not alone. One 2024 survey found that almost a third of American adults regularly doomscroll—that is, swipe through endless social media feeds—and millennials and Gen ...
The Medion Erazer Deputy 15 P1 prioritises power above all, offering some beefy 1080p gaming performance for the price and an excellent port selection for its modest outlay, plus average battery life.
The Medion Erazer Major 16 X1 is a very powerful gaming laptop for its price, offering some fantastic gaming performance plus a capable port selection, vibrant IPS screen and comfortable keyboard and ...
If you’ve ever thought a break from social media might be good for your head space, new research suggests you’re onto something. In a study of young adults published in JAMA Network Open, those who ...
As social media continues to rapidly evolve, so do questions about how it impacts health and well-being. Laura Marciano, a former research associate in the Department of Social and Behavioral Sciences ...
After months of negotiations, including those with an anonymous, unsolicited third party, Marlborough-based biotech firm Akoya Biosciences has officially been acquired by Quanterix, a fellow publicly ...
BILLERICA, Mass.--(BUSINESS WIRE)-- Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today ...
Explore data on 30 major news sources with our interactive tool Americans now navigate a quickly changing information environment, with a wide variety of news sources across many different platforms ...
After biotech firm Akoya Biosciences previously announced it would be acquired by Billerica-based research corporation Quanterix, the Marlborough-based company is now considering an unsolicited, ...
Akoya Biosciences (AKYA) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.35 per share a year ago. These figures ...
SAMBAI Selects Akoya’s PhenoCycler-Fusion Spatial Proteomics Technology for Large-Scale Cancer Study
SAMBAI, a team funded through the Cancer Grand Challenges initiative, reported that Akoya Biosciences’ PhenoCycler ®-Fusion system will be the foundational spatial proteomics technology used to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results